advertisement
Abstract #15658 Published in IGR 2-3
Directed therapy for specific glaucomas
Ritch ROphthalmology Clinics of North America 2000; 13: 429-441
Rapidly increasing understanding of the origin of disease states on a molecular, genetic, and biochemical level is opening new doors for treatment options, if not eventual cures. This article provides an overview of tailoring treatment to the underlying mechanism in angle-closure glaucoma and describes present and future approaches toward understanding and dealing with the two most commonly identifiable open-angle glaucomas, pigment dispersion syndrome and exfoliation syndrome.
Dr. R. Ritch, Glaucoma Services, New York Eye and Ear Infirmary, 310 East 14th Street, New York, NY 10003, USA
Classification:
11.1 General management, indication (Part of: 11 Medical treatment)
12.1 General management, indication (Part of: 12 Surgical treatment)